Gene · 2621
Papers3,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of oxytocin on the hair growth ability of dermal papilla cells. | Sci Rep | 2023 | 37863919 | PubTator, text mining | PubMed |
| Blocking of ebolavirus spread through intercellular connections by an MPER-specific antibody depends on BST2/tetherin. | Cell Rep | 2023 | 37858466 | PubTator, text mining | PubMed |
| Interaction, immune infiltration characteristics and prognostic modeling of efferocytosis-related subtypes in glioblastoma. | BMC Med Genomics | 2023 | 37853449 | PubTator, text mining | PubMed |
| Systemic inflammation early after kidney transplantation is associated with long-term graft loss: a cohort study. | Front Immunol | 2023 | 37849758 | PubTator, text mining | PubMed |
| Primary and acquired resistance to first-line therapy for clear cell renal cell carcinoma. | Cancer Drug Resist | 2023 | 37842234 | PubTator, text mining | PubMed |
| Pancreatic Cancer-Secreted Proteins: Targeting Their Functions in Tumor Microenvironment. | Cancers (Basel) | 2023 | 37835519 | PubTator, text mining | PubMed |
| Multi-Functional Regulation by YAP/TAZ Signaling Networks in Tumor Progression and Metastasis. | Cancers (Basel) | 2023 | 37835395 | PubTator, text mining | PubMed |
| Intervention of AXL in EGFR Signaling via Phosphorylation and Stabilization of MIG6 in Non-Small Cell Lung Cancer. | Int J Mol Sci | 2023 | 37834326 | PubTator, text mining | PubMed |
| AXL receptor tyrosine kinase modulates gonadotropin-releasing hormone receptor signaling. | Cell Commun Signal | 2023 | 37828510 | PubTator, text mining | PubMed |
| Ewing Sarcoma Single-cell Transcriptome Analysis Reveals Functionally Impaired Antigen-presenting Cells. | Cancer Res Commun | 2023 | 37823774 | PubTator, text mining | PubMed |
| Persistence is key: unresolved immune dysfunction is lethal in both COVID-19 and non-COVID-19 sepsis. | Front Immunol | 2023 | 37822940 | PubTator, text mining | PubMed |
| The role of the Gas6/TAM signal pathway in the LPS-induced pulmonary epithelial cells injury. | Mol Immunol | 2023 | 37820442 | PubTator, text mining | PubMed |
| Transcriptomic analysis reveals partial epithelial-mesenchymal transition and inflammation as common pathogenic mechanisms in hypertensive nephrosclerosis and Type 2 diabetic nephropathy. | Physiol Rep | 2023 | 37813528 | PubTator, text mining | PubMed |
| Identification and verification of an exosome-related gene risk model to predict prognosis and evaluate immune infiltration for colorectal cancer. | Medicine (Baltimore) | 2023 | 37800824 | PubTator, text mining | PubMed |
| Establishment of two oxaliplatin-resistant gallbladder cancer cell lines and comprehensive analysis of dysregulated genes. | Open Med (Wars) | 2023 | 37786776 | PubTator, text mining | PubMed |
| Genome-wide meta-analysis of 92 cardiometabolic protein serum levels. | Mol Metab | 2023 | 37778719 | PubTator, text mining | PubMed |
| Cellular and Molecular Mechanisms of the Tumor Stroma in Colorectal Cancer: Insights into Disease Progression and Therapeutic Targets. | Biomedicines | 2023 | 37760801 | PubTator, text mining | PubMed |
| Lung extracellular matrix modulates KRT5+ basal cell activity in pulmonary fibrosis. | Nat Commun | 2023 | 37758700 | PubTator, text mining | PubMed |
| Prognostic significance of TP53 and PIK3CA mutations analyzed by next-generation sequencing in breast cancer. | Medicine (Baltimore) | 2023 | 37747019 | PubTator, text mining | PubMed |
| Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma. | Front Oncol | 2023 | 37746265 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/papers?page=19